Tradestie Institutional Equity Comparison Engine

AYTU vs IBIO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AYTU Overall Edge

AYTU Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Valuation, Momentum & Technical while IBIO counters with relative strength in Growth & Margin. Fundamentally, AYTU trades at 9.2x Forward P/E with -14.4% operating margin (+6.4% YoY revenue) versus IBIO at N/M Forward P/E and -3025.6% operating margin (+975.0% YoY). In options structure, AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AYTU
AYTU 9.2x vs IBIO N/M Fwd P/E
Growth & Margin Winner IBIO
Op Margin -14.4% vs -3025.6% ยท YoY +6.4% vs +975.0%
Momentum & Technical Winner AYTU
1Y -12.1% vs -37.7% ยท 52W Pos 5% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AYTU NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap $19.6M
1M Return -11.27%
1Y Return -12.14%
Forward P/E 9.2x
Unified AI Score
48.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 64.0
IBIO NASDAQ
iBio, Inc. Common Stock
Pharmaceutical Preparations
$0.72
-2.04% 1D
Market Cap $53.7M
1M Return -6.46%
1Y Return -37.67%
Forward P/E N/M
Unified AI Score
46.0 / 100 HOLD
Tech 45.0 Fund 46.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AYTU -12.14% IBIO -37.67% Spread: +25.53 pp (AYTU Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AYTU Revenue IBIO Revenue AYTU Op. Margin IBIO Op. Margin Margin Edge
FY2019 $10M $0M -230.1% -782.4% AYTU
FY2020 $30M $0M -76.5% -854.9% AYTU
FY2021 $70M $0M -89.7% -1312.1% AYTU
FY2022 $100M $0M -113.7% -1576.3% AYTU
FY2023 $110M N/A -15.9% N/A AYTU
FY2024 $70M $0M -2.4% -7392.9% AYTU
FY2025 $70M $0M -11.8% -4650.5% AYTU
FY2026 $60M $0M -14.4% -35141.0% AYTU

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AYTU (6) vs IBIO (4)
Institutional Metric AYTU IBIO Criterion Row Winner
Market Capitalization Scale $19.6M $53.7M Larger Scale IBIO
Trailing P/E Ratio Valuation 9.2x N/M Lower Multiple AYTU
Forward P/E Ratio Valuation 9.2x N/M Lower Multiple AYTU
Revenue Growth (YoY) Growth +6.4% +975.0% Higher Growth IBIO
Operating Margin (TTM) Profitability -14.4% -3025.6% Higher Margin AYTU
Net Profit Margin Profitability -24.8% 0.0% Higher Margin IBIO
Return on Equity (ROE) Capital Efficiency -52.5% -51.8% Higher ROE IBIO
52-Week Range Position Momentum 5% ($2โ€“$3) 1% ($1โ€“$4) Stronger Trend AYTU
Beta / 30D Volatility Risk Regime 0.65ฮฒ ยท 35% Vol 2.07ฮฒ ยท 89% Vol Lower Realized Risk AYTU
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 46.0 / 100 (HOLD) Higher Composite AYTU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AYTU vs IBIO Buy Guide
AYTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AYTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IBIO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IBIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AYTU nor IBIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.